Corient Private Wealth’s Organon & Co OGN Stock Holding History
Bought
Maintained
Sold
Other funds holding OGN
PCM
AA
Corient Private Wealth's OGN Position: Q2 2026 in Review
Corient Private Wealth reduced its Organon & Co (OGN) stake by 6.9% in Q2 2026, selling an estimated $28.8K and leaving 32,772 shares worth $444K. The position accounts for ﹤0.01% of the portfolio, ranked #2307.
Corient Private Wealth first reported a position in OGN in Q4 2022 and has held it in 15 quarters since. The position peaked at $2.07M in Q2 2023. 636 funds tracked by Wall St. Rank hold OGN as of Q2 2026.
- Corient Private Wealth held 32,772 shares of Organon & Co worth $444K as of Q2 2026.
- Corient Private Wealth sold 2,412 Organon & Co shares in Q2 2026, an estimated $28.8K.
- Organon & Co made up ﹤0.01% of Corient Private Wealth's portfolio in Q2 2026, its #2307 holding.
- Corient Private Wealth first reported a position in Organon & Co in Q4 2022 and has held it in 15 quarters since.
- Corient Private Wealth's Organon & Co position peaked at $2.07M in Q2 2023.
- 636 funds tracked by Wall St. Rank held Organon & Co as of Q2 2026.
Based on Corient Private Wealth's 13F filing for Q2 2026, filed 12 Aug 2026.